Safety and efficacy of a recombinant hepatitis E vaccine.
about
Health, human rights, and the conduct of clinical research within oppressed populationsHepatitis E epidemic, UgandaAcute liver failure including acetaminophen overdoseStructure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor bindingEnhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cellsHepatitis E virus as an emerging zoonotic pathogenHepatitis VaccinesHepatitis E virus infection: Epidemiology and treatment implicationsCurrent Knowledge on Hepatitis EChronic hepatitis E: A brief reviewHepatitis E, a vaccine-preventable cause of maternal deathsLessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteinsGeneral Epidemiological Parameters of Viral Hepatitis A, B, C, and E in Six Regions of China: A Cross-Sectional Study in 2007Molecular Biology and Infection of Hepatitis E VirusAcute Hepatitis E: Two Sides of the Same CoinBats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family HepeviridaeEvolution of the hepatitis E virus hypervariable region.Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy.Hepatitis E infection among Ghanaians: a systematic reviewAdvances in hepatitis E - II: Epidemiology, clinical manifestations, treatment and prevention.Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles.A Comprehensive Study of Neutralizing Antigenic Sites on the Hepatitis E Virus (HEV) Capsid by Constructing, Clustering, and Characterizing a Tool Box.Subduing the hepatitis E Python.Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance dataHepatitis E virus: animal reservoirs and zoonotic riskTime trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark.Enteric hepatitis viruses.Hepatitis E-associated encephalopathy in a renal transplant recipient.Transmission, diagnosis, and management of hepatitis E: an updateA systematic review of the epidemiology of hepatitis E virus in Africa.SPF rabbits infected with rabbit hepatitis E virus isolate experimentally showing the chronicity of hepatitisHepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation.Subviral particle as vaccine and vaccine platform.Zoonotic hepatitis E: animal reservoirs and emerging risksSeroepidemiology of a second epidemic of hepatitis E in a population that had recorded first epidemic 30 years before and has been under surveillance since then.Outbreak of hepatitis E in urban Bangladesh resulting in maternal and perinatal mortalityHepatitis E virus ORF2 protein activates the pro-apoptotic gene CHOP and anti-apoptotic heat shock proteinsNaturally occurring animal models of human hepatitis E virus infection.Molecular virology of hepatitis E virus.Novel risk factors associated with hepatitis E virus infection in a large outbreak in northern Uganda: results from a case-control study and environmental analysis.
P2860
Q24288922-86C632E7-D4B4-4395-A3F5-00CF5415D43BQ24609019-32E91C59-F3FB-4651-B9E2-866BEA721B3DQ24647134-E3326447-650C-499C-B8B7-DEEDD1D72EE8Q24655874-189C010B-EF71-410E-9F3C-78CDA51E926CQ24658494-6D3BFFE5-C361-4D26-B80D-9D40F3AA4D53Q26751267-CAF699FE-5155-4F9A-AC93-7BD9E20C031BQ26765433-41C57495-E6BB-4795-983E-C33FF5FAD901Q26777044-F498C0B5-BA75-439E-B07E-70501A710669Q26782030-6E719AB0-43B6-4EBC-A94D-9698426E1314Q26784271-345263AF-124D-422E-A2EC-A3A035238A4DQ26852254-85CD2F15-E6D6-4280-86F0-544237A20E93Q27013018-5244AB21-2415-4CD3-A91D-49454BFFB32CQ27490512-0920C088-A987-4475-8F1E-5879C4E9FE73Q28066101-D16CB7C8-59D2-4B4F-944F-4D3FDC9F6AFFQ28069291-81E3570B-BEE1-43FC-9C1C-6F24D01267A2Q28728496-EAA9F4B4-5BF0-4075-8A29-32E4B9F38961Q30010037-59A2F596-81EB-457F-87B8-F98B7B5A5EE4Q30234629-9C57281C-180A-42A4-902D-862CF2814892Q30238550-623DD74E-7944-455E-8F2C-000421506402Q30251421-0C0F2A1F-08AF-4CFF-BCA5-2ECC0B3A0863Q30366046-8DF7AA00-FA7C-4450-B5F3-ECB2976B4FEDQ30375781-DE0EC909-7F0B-49EB-9315-50EBEF46BE60Q33369994-5C93EF16-5F60-439D-ACB4-1B3301A7A405Q33422124-5B7B186E-9790-4413-A6BD-FE275C8E9CD0Q33429348-641E4495-FC7B-4BE0-9AA8-124067C36C65Q33577032-17CA5879-022F-482E-AC8E-166EE8ACE25FQ33596383-734DECD7-69C4-4FE3-81CD-19862DD42151Q33629182-27EECF9A-3DB3-4906-911C-31B94967C8EBQ33734018-F2540D3B-C5EA-4C45-A567-903B72C31AEDQ33747037-D126908C-BF30-4CC9-943C-F214FCF09842Q33769042-5862EF39-E143-4456-BC7C-F7048B2BE723Q33769640-D688FAA9-2E13-4C87-AE11-1295C0C6D367Q33812653-82F84024-1D31-486A-A294-1A72E50FC11FQ33832118-FE17CF59-474B-4CF9-9AC7-21DEC9939F55Q33977156-60FA21CB-6D6C-4935-9EE9-585A3ADBE8BCQ34034046-9DED71D8-3DA2-4C63-8DF7-7B9903AA9CBEQ34038276-0387822A-FCED-401C-9F84-2F3DB1AEFD55Q34152290-152CFF14-6D95-447A-BF3D-63A52E6C1A3AQ34166393-8C0C5D53-37F4-45CE-B815-11F9FEFD0325Q34240197-80A2A6BC-92CA-4DF0-A754-48FE8121AAA1
P2860
Safety and efficacy of a recombinant hepatitis E vaccine.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Safety and efficacy of a recombinant hepatitis E vaccine.
@ast
Safety and efficacy of a recombinant hepatitis E vaccine.
@en
Safety and efficacy of a recombinant hepatitis E vaccine.
@nl
type
label
Safety and efficacy of a recombinant hepatitis E vaccine.
@ast
Safety and efficacy of a recombinant hepatitis E vaccine.
@en
Safety and efficacy of a recombinant hepatitis E vaccine.
@nl
prefLabel
Safety and efficacy of a recombinant hepatitis E vaccine.
@ast
Safety and efficacy of a recombinant hepatitis E vaccine.
@en
Safety and efficacy of a recombinant hepatitis E vaccine.
@nl
P2093
P356
P1476
Safety and efficacy of a recombinant hepatitis E vaccine.
@en
P2093
Assad Safary
Bruce L Innis
David W Vaughn
Durga Man Joshi
Gyan Bahadur Thapa
Jitvimol Seriwatana
Khin Saw Aye Myint
Mammen P Mammen
Marc Fourneau
Marie Pierre David
P304
P356
10.1056/NEJMOA061847
P407
P577
2007-03-01T00:00:00Z